TLDR: Haut.AI has announced its participation as a Tier 3 Sponsor for the 12th Aging Research & Drug Discovery Meeting (ARDD 2025), a leading global conference focusing on advancements in longevity and biopharmaceutical innovation.
Haut.AI, a prominent entity in its field, has officially confirmed its role as a Tier 3 Sponsor for the upcoming 12th Aging Research & Drug Discovery Meeting (ARDD 2025). This significant event, recognized as the world’s largest conference dedicated to aging research within the biopharmaceutical industry, is scheduled to take place from August 25 to August 29, 2025. The conference will be held both on-site at the Ceremonial Hall of the University of Copenhagen and virtually, offering a hybrid attendance model.
ARDD 2025 is poised to be a pivotal gathering, bringing together an esteemed roster of participants including Nobel laureates, top executives from the pharmaceutical industry, and influential leaders in healthcare delivery. The conference serves as a crucial platform for fostering progress in longevity biotechnology globally. A key highlight of the meeting will be discussions on the latest breakthroughs in artificial intelligence and its transformative applications within the biopharmaceutical sector, underscoring the interdisciplinary nature of modern scientific advancement.
Also Read:
- Almirall and Absci Broaden AI-Powered Drug Discovery Partnership with New Dermatology Target
- BostonGene Recognized for Leading AI Innovation in Drug Discovery at 2025 AI Breakthrough Awards
Haut.AI’s sponsorship aligns with a diverse group of organizations supporting ARDD 2025. Other notable Tier 3 sponsors include Academy for Health & Lifespan Research, TruDiagnostic, Accelerated Biosciences, Aptah Biosciences, LongGame Ventures, BioAge, Rejuve.Bio, Rejuvenate Biomed, Retro, VitaDAO, Molecule, Mitra Bio, One Skin, Repair Biotechnologies, Institute of Healthier Living Abu Dhabi, The Thalion Initiative, Deep Origin, Omniscope, and Infinita City. The conference also boasts high-profile Tier 1 sponsors such as Insilico Medicine, Longevity Pledge Alex Zhavoronkov, Maxwell Biosciences, LongeVC, Human Longevity, and the University of Copenhagen, alongside Tier 2 sponsors like L’Oréal Research & Innovation, Life Biosciences, and Gero. This broad spectrum of sponsors highlights the collaborative effort across various sectors to accelerate research and development in aging and longevity.
